Background and Purpose This study was conducted to determine whether glucose intolerance and diabetes increase the risk of thromboembolic, hemorrhagic, and total stroke independent of other risk factors.
Glucose Intolerance and 22-Year Stroke Incidence
D espite the dramatic decline in stroke incidence and mortality over the past 30 years, 1 ' 2 stroke remains the third leading cause of death in the United States and is responsible for substantial disability. 3 Individuals with diabetes are at especially high risk of stroke compared with persons without diabetes, 4 -10 yet reasons for this excess remain unclear. Some investigations have suggested that the atherosclerotic process might be accelerated in diabetic subjects. 1112 As reviewed recently, 1315 potential mechanisms include dyslipidemia, 16 insulin resistance and hyperinsulinemia, 1620 increased glycosylation, 21 enhanced lipoprotein oxidation, 22 elevated hormone or growth factor levels leading to smooth muscle cell proliferation, 23 and a procoagulant state. 17 ' 24 -25 Few studies have examined whether elevated levels of serum glucose in persons not known to have diabetes are associated with an increased risk of stroke. 8 - 9 In addition, whether diabetes or glucose intolerance has an independent effect on stroke, apart from the potential influence on other cardiovascular risk factors known to increase atherosclerosis and clinical disease, has not been fully clarified. Whether the impact of diabetes and glucose intolerance on subsequent stroke is the same in younger and older subjects and in those with and without hypertension is also unclear. The association of glucose intolerance and diabetes with subsequent incidence of stroke was examined prospectively in a cohort of middle-aged JapaneseAmerican men from the Honolulu Heart Program who were followed for approximately 22 years. Incidence rates and risk estimates are compared for thromboembolic and hemorrhagic stroke. Adjustment for potential confounding and mediating factors is used to determine whether observed relations are independent of other cardiovascular risk factors.
Subjects and Methods
The Honolulu Heart Program was initiated as a component of a larger comparative study involving men of Japanese ancestry who were residing in Japan, Hawaii, and California. Between 1965 and 1968, 8006 Japanese-American men who were living on the island of Oahu and were born between 1900 and 1919 completed a baseline examination. Subjects, then aged 45 to 68 years, completed an interview and a variety of procedures, which included an electrocardiogram, measurements of blood pressure, physical examination, anthropometry, and nonfasting measurements of cholesterol, triglyceride, uric acid, and glucose 1 hour after a 50-g load, according to recommended rese'arch protocols at that time. Subjects were classified as hypertensive if their systolic or diastolic blood pressure was 140/90 mm Hg or greater or they were taking antihypertensive medication. A pack-year summary measure was derived for smoking. Alcohol intake was determined by recording usual monthly intake of beer, wine, or liquor and converted to milliliters of ethanol consumed per day. A physical activity index was derived by summing the product of the number of hours spent in rive activity levels and a weighting factor based on the oxygen consumption required for each activity. Further details of the study design and data collection methods have been published previously.
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Of the 8006 men examined, 7589 were free of prevalent coronary heart disease (angina, coronary insufficiency, and myocardial infarction) and stroke (definite history or existing neurological deficits with possible history) at baseline. Forty men had missing glucose measurements, leaving 7549 subjects who constituted the study population.
Diabetes and Glucose Intolerance
Because current World Health Organization (WHO) criteria for diabetes mellitus 28 were unavailable at baseline, men were classified into four glucose tolerance categories based on questionnaire information and the 1-hour postload glucose measurement (Table 1) , consistent with a previous investigation. 29 The category labeled "low normal" included men with or without a positive history of diabetes who were not on diabetic medication (oral hypoglycemic agent or insulin) and whose glucose level was less than 151 mg/dL (approximate 50th percentile). Similar subjects who had glucose levels between 151 and 224 mg/dL were considered "high normal." A group labeled "asymptomatic high" consisted of men who denied a history of diabetes, were not taking diabetic medication, and had a glucose level of 225 mg/dL or greater (approximate 90th percentile). Men were defined as having "known diabetes" if they (1) reported a positive history of diabetes and were taking diabetic medication regardless of glucose level or (2) had a positive history of diabetes and were not taking diabetic medication but had a glucose level of 225 mg/dL or greater.
Stroke
Subjects were followed continuously from baseline through 1988 for cardiovascular disease using a comprehensive surveillance system based on hospital and mortality records. Hospital discharge summaries, autopsy reports, and mortality data from all major hospitals on Oahu were reviewed, and standardized criteria were used to identify incident cases. 30 Medical practice on Oahu was such that virtually all suspected cases of stroke were hospitalized. Completeness of follow-up has been quite high because of the low rate of out-migation (<0.2%/y) and the high proportion of subjects who participated in subsequent examinations (95% and 90% for the second and third examinations, respectively).
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A diagnosis of definite stroke was made by a neurologist when a neurological deficit was accompanied by blood in cerebrospinal fluid or by evidence of an infarct or hemorrhage on nuclear brain scan or computed tomography (CT). Probable strokes included neurological deficits that persisted at least 2 weeks or until death but were not accompanied by positive cerebrospinal fluid, brain scan, or CT findings. Based on this evidence, as well as clinical and pathological information during hospitalization, surgery, or autopsy, 32 it was usually possible to classify strokes as thromboembolic or hemorrhagic. Possible strokes (neurological deficit lasting at least 24 hours but less than 2 weeks or of unknown duration) were not included because diagnostic certainty was lower and classification by stroke type was accomplished in a smaller proportion. A stroke was considered thromboembolic if the focal neurological deficit occurred usually without prolonged unconsciousness, nuchal rigidity, fever, pronounced leukocytosis, or blood in the spinal fluid. Identification of hemorrhagic stroke was based on a focal neurological deficit accompanied by loss of consciousness, headache, and blood present in spinal fluid from an atraumatic lumbar puncture or on the basis of CT or surgical findings. 32 -33 Subjects who developed neurological events attributable to other causes, such as blood dyscrasias, neoplasia, head injury, surgical accident, meningoencephalitis, fat embolism, epilepsy, or cardiac arrest, were not included in the stroke category.
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Statistical Analysis
Age-adjusted mean levels and prevalence of cardiovascular risk factors were compared across the four glucose tolerance categories using a general linear models procedure and logistic regression available in SAS 34 -33 with the low-normal group as a reference. Age-adjusted incidence rates of thromboembolic, hemorrhagic, and total stroke per 1000 person-years of observation were calculated using the entire study population as the standard. To determine whether diabetes or glucose intolerance was independently associated with subsequent stroke, the Cox proportional hazards model was used to calculate relative risks (RRs) of stroke, adjusted for age and cardiovascular risk factors, using the low-normal group as the reference. Analyses were also conducted excluding the relatively few men in the low-and high-normal groups who only reported a positive history of diabetes. In addition, to assess whether age and hypertension modified the relation between glucose intolerance and stroke, adjusted RRs of stroke were compared across glucose tolerance categories separately for younger (aged 45 to 54 years) and older (aged 55 to 68 years) men, as well as for men with and without hypertension.
Results
In this study 3795 of the 7549 men (50.3%) met the criteria for the low-normal group with optimal glucose tolerance ( Table 1 ). The vast majority of subjects in the low-and high-normal groups (97.5% and 94.6%, respectively) did not report a history of diabetes. A total of 593 subjects (7.9%) had elevated glucose levels (>225 mg/ dL) but did not report a history of diabetes or treatment for diabetes. Known diabetes, as defined in this study, was present in 5.9% (442/7549) of the study population, with more than two thirds (72.4%) reporting use of diabetic medication.
Compared with the low-normal group, age-adjusted mean levels of body mass index, glucose, cholesterol, triglyceride, hematocrit, pack-years of smoking, alcohol intake, and age-adjusted prevalence of hypertension and left ventricular hypertrophy or strain on electrocardiogram were significantly elevated and successively higher in the high-normal and asymptomatic high groups, respectively (Table 2) . Men with known diabetes had the highest body mass index, cholesterol, and triglyceride and the lowest physical activity index. Prevalence of hypertension was lower, and mean levels of glucose, uric acid, pack-years of smoking, and alcohol intake were also lower in men with known diabetes compared with the asymptomatic high group, perhaps reflecting results of increased medical care and lifestyle modification among men with clinically recognized diabetes.
During the 22-year follow-up period 538 men developed a stroke. A total of 374 were classified as thromboembolic, 128 as hemorrhagic, and 36 as of unknown etiology. Age-adjusted incidence rates of total stroke were 3.51, 4.08,6.16, and 8.15 per 1000 person-years for men in the low-normal, high-normal, asymptomatic high, and known diabetes groups, respectively. Ageadjusted incidence rates of thromboembolic stroke increased successively across worsening categories of glucose intolerance, with twofold higher rates in the asymptomatic hyperglycemia group and nearly threefold higher rates in the known diabetes group compared with men in the low-normal category (Figure) . In contrast, incidence rates of hemorrhagic stroke did not vary substantially across glucose tolerance categories.
The age-adjusted RRs of thromboembolic stroke increased with worsening glucose intolerance category and were all significantly elevated compared with the low-normal group (Table 3) . Some attenuation in RRs was observed after additional adjustment for body mass index, hypertension, left ventricular hypertrophy or strain, cholesterol, triglycerides, uric acid, hematocrit, pack-years of smoking, alcohol intake, and physical activity. The RR for the high-normal group was no longer significantly elevated (RR=1.12; 95% confidence interval [CI]=0.88 to 1.43), yet RRs for the asymptom-
Known
Bar graph shows age-adjusted incidence of thromboembolic and hemorrhagic stroke per 1000 person-years by glucose tolerance category. See Table 1 for description of glucose tolerance categories. Patterns for all strokes combined were similar to those observed for thromboembolic stroke because nearly 70% of all strokes in this cohort were thromboembolic in origin. The 63% excess in the age-adjusted rate of all strokes combined, experienced by subjects in the asymptomatic high group compared with those in the low-normal group, was reduced to a 27% excess, which was no longer significantly elevated when other cardiovascular risk factors were controlled. However, the rate of total stroke experienced by subjects with known diabetes was more than double the rate observed in the low-normal group with and without adjustment for other risk factors.
Adjusted RRs of stroke by glucose tolerance category are presented separately for men aged 45 to 54 years and 55 to 68 years and for men who had and did not have hypertension at baseline (Table 4) . Relative risks of thromboembolic stroke for the asymptomatic high and known diabetes groups were somewhat higher in younger than older men (1.62 and 3.08 versus 1.34 and 2.11, respectively). For hypertensive and nonhypertensive subjects, RRs of thromboembolic stroke were similar across glucose tolerance categories. Subjects with known diabetes had significantly elevated risk factoradjusted RRs of thromboembolic and total stroke in both age groups and both hypertensive groups. As in the combined analysis, RRs of hemorrhagic stroke were not significantly elevated.
Discussion
Japanese-American men with mildly elevated glucose, asymptomatic hyperglycemia, and known diabetes experienced an increased risk of thromboembolic but not hemorrhagic stroke relative to subjects with low baseline glucose levels in 22 years of follow-up. In general, the excess risk was independent of other cardiovascular risk factors in asymptomatic high and diabetic subjects. A greater proportion of the excess risk in the high-normal and asymptomatic high groups appears to be explained by other cardiovascular risk factors than in the known diabetic group.
These findings are consistent with an earlier investigation of this cohort in which diabetes and elevated glucose in nondiabetics were associated with an increased 12-year risk of stroke. 9 This report extends the previous investigation by adding 10 stroke. An attempt was made to control for the potential confounding or mediating effects of these risk factors in the assessment of whether diabetes or glucose intolerance has an independent effect on risk of stroke. Left ventricular hypertrophy or strain at baseline could be an intermediate variable in a causal pathway leading from hypertension to stroke. We elected to control for this variable because it has been identified as an important predictor of stroke 32 - 36 and was related to glucose tolerance status. Excluding this variable from the model did not appreciably alter associations between glucose tolerance categories and stroke. Results from a previous report were unchanged when strokes preceded by left ventricular hypertrophy or atrial fibrillation identified at either of the two subsequent examinations were excluded and when strokes preceded by a myocardial infarction during follow-up were also excluded. 9 Left ventricular hypertrophy and atrial fibrillation are two manifestations of cardiac impairment, both of which have been strongly linked with subsequent risk of stroke. 46 Atrial fibrillation or flutter was identified infrequently (0.08%) in this cohort, whereas left ventricular hypertrophy or strain was more common (15%) at baseline. 47 Current WHO criteria for diabetes 28 were not available at the baseline examination (nonfasting 50-g glucose load was used rather than the WHO fasting 75-g load), thus limiting comparability with some studies. It is likely that some of the subjects in the asymptomatic high group would have had unrecognized diabetes at baseline and that others in this group would have been classified as impaired glucose tolerant if WHO criteria were employed. However, gradients in incidence and mortality across categories of glucose tolerance based on the 1-hour 50-g glucose load in this and previous studies 9 - 29 -3648 suggest that this method provides an effective indicator of risk.
During the relatively long follow-up period of 22 years it is likely that a number of subjects who were initially free of diabetes went on to develop it. The comprehensive hospital surveillance for cardiovascular disease in the Honolulu Heart Program did not provide the opportunity to ascertain incident cases of diabetes with adequate certainty. In addition, it is likely that many of the milder cases of diabetes would have been treated on an outpatient basis. The misclassification resulting from not identifying incident cases as diabetic subjects most likely would have diminished any of the associations observed.
Similarly, inclusion of a relatively small number of subjects (<5%) with a history of diabetes who were not receiving diabetic medication in the low-and highnormal groups also could have diminished associations. These subjects with only an unconfirmed history of diabetes were not included in the known diabetes group because diagnostic certainty was lower and they may not have been identified as diabetic if WHO criteria were used. When these subjects were excluded (93 from the low-normal and 147 from the high-normal groups), age-adjusted incidence of diabetes and risk factoradjusted RRs reflecting the association between glucose tolerance and stroke were nearly identical. On the other hand, risk of stroke could differ for these subjects compared with the vast majority who were free of diabetic history and medication use in these two groups.
Surveillance for stroke was based on a comprehensive effort to identify all cases of stroke resulting in hospitalization on the island of Oahu. Comparisons with reported history of stroke in this cohort indicate that ascertainment was virtually complete. The low rate of out-migration and the high participation rate at subsequent examinations 31 increase the likelihood that the strokes identified were representative of all strokes in the cohort.
Whether findings from Japanese-American men in this study can be generalized to women and men from other ethnic groups is not clear. Diabetes appears to be a stronger risk factor for cardiovascular disease in women than in men. 6 - 49 Similarly, the impact of diabetes and perhaps impaired glucose tolerance on risk of stroke could be somewhat different in white and other populations compared with Japanese-Americans. However, it is also likely that similar pathogenetic mechanisms are involved in each sex and ethnic group.
Further research involving the etiology and pathogenesis of both thromboembolic and hemorrhagic stroke is clearly needed. Of particular interest is the mechanism by which glucose intolerance and diabetes lead to development of thromboembolic stroke, a process that apparently may not lead to an increased risk of hemorrhagic stroke. Because serum cholesterol level may be directly related to thromboembolic stroke 32 54 In a recent study prevalence of diabetes was significantly higher among Japanese subjects with atherothrombotic occlusion of the internal carotid and basilar arteries than in control subjects. 55 Serum glucose was also weakly associated with large-vessel (circle of Willis) but not intracerebral small-vessel atherosclerosis after adjusting for other risk factors. 56 Because of the strong association between hypertension and diabetes, possibly due to an insulin resistance syndrome, 1 *' 18 -2 " and their associations with cardiovascular outcomes such as stroke, it may be difficult to isolate an independent effect of diabetes. In addition to the adjustment for hypertension in a multivariate Cox model in this study, known diabetes was also independently associated with thromboembolic stroke in subjects who did not have hypertension. This strengthens the evidence for an independent role of diabetes as a risk factor for thromboembolic stroke. In addition, the similar associations between glucose intolerance and thromboembolic stroke for hypertensive and nonhypertensive subjects indicate that hypertensive status does not appear to modify the impact of glucose intolerance or diabetes on the risk of stroke.
Risk of thromboembolic stroke remained significantly elevated after adjustment for other risk factors, especially in younger (aged 45 to 54 years) but also older (aged 55 to 68 years) men with known diabetes compared with those in the low-normal category. Risk factor-adjusted RRs were elevated but not significantly in young and old men with asymptomatic hyperglycemia. It is possible that the adverse impact of an elevated glucose level may be explained to some extent through its effect on other cardiovascular risk factors. These results suggest that efforts to improve risk factor levels for thromboembolic stroke, particularly in younger but also in older persons with diabetes, are clearly indicated.
The observation of an excess risk of thromboembolic stroke among subjects with asymptomatic hyperglycemia and even high-normal levels of glucose is consistent with the increased risk experienced by individuals with impaired glucose tolerance. 8 Some of this excess is explained by other risk factors, yet subjects with known diabetes experience an increased risk of thromboembolic stroke that was clearly independent of other risk factors. It appears that an elevated glucose level in subjects without clinically apparent diabetes may serve as a marker for elevated cardiovascular risk factors in general, 5760 an increased risk of subsequent diabetes, 61 " 67 and possibly an increased risk of thromboembolic stroke. From a public health perspective, identification of individuals with elevated glucose levels may provide an opportunity for intervention. Increasing physical activity and reducing overweight may prove to be effective measures. The evidence appears stronger in the case of known diabetes, in which efforts to improve modifiable risk factors for thromboembolic stroke may provide considerable benefit.
